CAS: 5441-51-0; 4-Ethylcyclohexanone

该化合物是带有分子式C8H14O的圆形酮,在环环的4位置上有一个乙基替代体,该化合物通常用作有机合成的中间体,特别是在生产药品,香味和特殊化学品方面,其结构特性,包括氯酮功能和烷基替代,使它成为进一步功能化的多功能构件.环己酮核心提供了稳定性,而乙基组则增加了有机溶剂的溶解性,促进了减少,凝聚和添加 Grignard等反应.其一贯的纯度和定义明确的再活性特征确保了合成应用的可靠性能.

结构式图片

相似化合物

4534-74-1 5441-51-0 61203-83-6

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号4534-74-1 4-乙基环己醇(顺反异构体混和物) | CAS号1515-95-3 4-乙基苯甲醚 | CAS号74128-81-7 4-ethylidene-cy... | CAS号31646-64-7 4-ethenylcycloh... | CAS号123-07-9 4-乙基苯酚 | CAS号1678-91-7 乙基环己烷 | CAS号100-40-3 4-乙烯环己烯 | CAS号5599-49-5 3-乙基咔 | CAS号4534-74-1 4-乙基环己醇(顺反异构体混和物) | CAS号1217254-21-1 trans-4-ethyl-1... | CAS号19781-62-5 反-4-乙基环己醇 | CAS号19781-61-4 cis-4-ethylcycl... | CAS号60-12-8 苯乙醇 | CAS号99-96-7 4-羟基苯甲酸 | CAS号1217254-25-5 trans-4-(1-hydr... | CAS号1217254-28-8 4-(1S-hydroxyet...

合成工艺路线路线简述

    4-亚乙基-环己-2-烯酮置于钯 氢气体系中,化学反应生成 4-乙基环己酮
    参考文献:Phase-Transfer Catalyzed Reactions. 5. Dramatic Effect Of The Concentration Of Base On The Dimerization Of Crotonaldehyde
    标题:Phase-Transfer Catalyzed Reactions. 5. Dramatic Effect Of The Concentration Of Base On The Dimerization Of Crotonaldehyde
    摘要:
    DOI:10.1021/jo01305A012

    海关参考信息

    专利信息


    专利号:US-8053161-B2
    优先权日:2006-09-25
    标 题 :Resist composition, resin for use in the resist composition, compound for use in the synthesis of the resin, and pattern-forming method using the resist composition
    发明人:WADA KENJI; SAEGUSA HIROSHI
    权利人:FUJIFILM CORP
    摘要:A resist composition comprises: (A) a resin capable of increasing its solubility in an alkali developer by action of an acid; (B) a compound capable of generating an acid upon irradiation with actinic ray or radiation; (C) a resin having at least one of a fluorine atom and a silicon atom; and (D) a solvent, wherein the resin (C) has a degree of molecular weight dispersion of 1.3 or less and a weight average molecular weight of 1.0×10 4 or less.

    专利号:US-9709891-B2
    优先权日:2005-12-09
    标 题:Positive resist composition, resin used for the positive resist composition, compound used for synthesis of the resin and pattern forming method using the positive resist composition
    发明人:KANDA HIROMI; KANNA SHINICHI
    权利人:FUJIFILM CORP
    摘要:A positive resist composition comprises: (A) a resin of which solubility in an alkali developer increases under an action of an acid; (B) a compound capable of generating an acid upon irradiation with actinic rays or radiation; (C) a resin having at least one of a fluorine atom and a silicon atom; and (D) a solvent; and a pattern forming method using the positive resist composition.

    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6849650-B2
    优先权日:1998-02-27
    标 题:Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THORSETT EUGENE D; PORTER WARREN J; NISSEN JEFFREY S; LATIMER LEE H; AUDIA JAMES E; DROSTE JAMES
    权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:EP-0951466-B1
    优先权日:1996-12-23
    标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:WU JING; TUNG JAY S; THORSETT EUGENE D; PLEISS MICHAEL A; NISSEN JEFFREY S; NEITZ JEFFREY; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; DROSTE JAMES J; HENRY STEVEN S; MCDANIEL STACEY L; SCOTT WILLIAM L; STUCKY RUSSELL D
    权利人:ELAN PHARM INC; LILLY CO ELI
    摘要:Disclosed are compounds for Formula (I) wherein the substituents are as defined in the claims which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    烟台万霖精细化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.winningchem.com
    电话: 0535-5570816 13964502016👤
    📞烟台万霖精细化工有限公司 ⚠️参考联系方式

    销售电话:0535-5570816 13964502016
    邮箱:sales@winningchem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海蓝润化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.longrunchem.com
    企业联系电话:021-69515658;13701998368👤
    📞上海蓝润化学有限公司 ⚠️参考联系方式
    联系人:路小姐
    电话:021-69515658;13701998368
    手机:13701998368
    传真:QQ:819185261
    邮箱:longrunchem@163.com
    通信地址: 上海市青浦区重固镇赵重公路2278号5号楼4层C区34座
    邮编: 201800
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市青浦区重固镇赵重公路2278号5号楼4层C区34座
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Santana, V. C. S.; Munaretto, L. S.; de Lucca, E. C., Jr., Science of Synthesis Knowledge Updates, (2022) 1, 214.
    摘要:Jie, X.; Su, W., Science of Synthesis, (2022) , 1.
    摘要:de Gonzalo, G.; van Berkel, W. J. H.; Fraaije, M. W., Science of Synthesis: Biocatalysis in Organic Synthesis, (2015) 3, 195.
    摘要:Muñiz, K., Science of Synthesis: Catalytic Oxidation in Organic Synthesis, (2017) 1, 1.
    摘要:Wang, L.; Liu, M.; Cheng, J., Science of Synthesis: Knowledge Updates, (2024) 1, 174.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知